Skip to content

Effects of Naproxen on Physical Performance

Effects of Naproxen on Physical Performance

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00410995
Enrollment
40
Registered
2006-12-13
Start date
2004-05-31
Completion date
2006-08-31
Last updated
2007-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Physically fit volunteers

Brief summary

The purpose of this study is to determine the effect of daily use of Naproxen (a commonly used over-the-counter NSAID) on the physical performance of athletes, as measured by maximum oxygen consumption.

Interventions

DRUGNaproxen

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age equal to or greater than18 years of age 2. No history of allergy or adverse reaction to any NSAID 3. No use of any NSAID in past 2 weeks 4. No history of peptic ulcer disease (PUD), gastroesophageal disease (GERD), or gastritis 5. No major medical history including but not limited to diabetes, hypertension, asthma, kidney disease and coronary artery disease 6. Currently not taking any medication including oral contraceptives

Exclusion criteria

1. Age \< 18 years of age 2. History of allergy or adverse reaction to any NSAID 3. Use of any NSAID in past 2 weeks 4. History of a bleeding disorder 5. History of PUD, GERD, or gastritis 6. Pregnant 7. A medical history of diabetes, hypertension, asthma, kidney disease or coronary artery disease 8. Taking any medication including oral contraceptives

Design outcomes

Primary

MeasureTime frame
Effects on physical performance in terms of maximum oxygen consumption

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026